Active Pharmaceutical Ingredients (API) Market Analysis by Growth Rate and Trends with Forecast to 2025
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
molecules. The R&D investment of the company are no longer valuable after patent expiration. Thus, the <strong>API</strong><br />
outsourcing trend in rising.<br />
Synthesis Type Insights<br />
Based on synthesis type, the market is categorized in<strong>to</strong> synthetic <strong>and</strong> biotech. Various methods are adopted <strong>by</strong> the<br />
manufacturing companies depending up on the complexity of the molecule required. Synthetic drugs are<br />
manufactured on the basis of organic chemistry in contrast <strong>to</strong> biotechnology based drugs, which are produced <strong>by</strong><br />
utilizing molecular techniques. Further classification of biotech segment is recombinant proteins, monoclonal<br />
antibodies <strong>and</strong> vaccines.<br />
In 2015, synthetic segment held the largest share. The key fac<strong>to</strong>rs for the biotech <strong>API</strong>s segment growth are large R&D<br />
investment for new biosimilars, increasing dem<strong>and</strong> for protein-based medicines, <strong>and</strong> rising focus of key manufacturers<br />
<strong>to</strong>ward biological drugs.<br />
Manufacturer Type Insights<br />
Based on the type of manufacturer, it is categorized in<strong>to</strong> outsourced or merchant or in-house or captive <strong>API</strong>s. According<br />
<strong>to</strong> market estimates, in 2015, in-house <strong>API</strong>s was the largest segment <strong>and</strong> outsourced <strong>API</strong>s are anticipated <strong>to</strong> be the<br />
fastest growing market.<br />
All pharmaceutical companies does not have separate unit for the formulation of <strong>API</strong>. This has led <strong>to</strong> rise in the<br />
outsourcing of the molecules from the production sites. The need of investment in expensive production processes is<br />
eliminated <strong>by</strong> the outsourcing.<br />
Request Sample Copy of this <strong>Market</strong> Research @<br />
https://www.millioninsights.com/industry-reports/active-pharmaceutical-ingredients-api-market/request-sample<br />
Type Insights<br />
Based on the type, <strong>API</strong>s are classified in<strong>to</strong> innovative <strong>and</strong> generics. Br<strong>and</strong>ed products come under innovative type,<br />
whereas the generic drugs are the ones, which are available OTC (over the counter). Owing of high rate of prescription,<br />
high drug development initiatives, <strong>and</strong> high price, the innovative <strong>API</strong>s segment dominated in 2015.<br />
Generic segment is anticipated <strong>to</strong> be fastest-growing type, due <strong>to</strong> expirations of patents of various blockbuster drugs.<br />
Patent expirations of br<strong>and</strong>ed drugs have very serious negative impacts on the drug producers, as the companies face<br />
the tremendous loss after expiration. Hence the drug manufacturers prefer more generic drugs than the br<strong>and</strong>ed ones.<br />
Application Insights
Change language